Results 241 to 250 of about 168,641 (363)

Endogenous C-type natriuretic peptide offsets the pathogenesis of steatohepatitis, hepatic fibrosis, and portal hypertension. [PDF]

PNAS Nexus
Perez-Ternero C, Li W, Aubdool AA, Goldin RD, Loy J, Devalia K, Alazawi W, Hobbs AJ.   +7 more
europepmc   +1 more source

Local Delivery of Single Low-Dose of C-Type Natriuretic Peptide, an Endogenous Vascular Modulator, Inhibits Neointimal Hyperplasia in a Balloon-Injured Rabbit Iliac Artery Model

, 2002
Satoshi Yasuda, Masahiko Kanna, Satoru Sakuragi, Sunao Kojima, Yasuhide Nakayama, Shunichi Miyazaki, Takehisa Matsuda, Kenji Kangawa, Hiroshi Nonogi   +8 more
openalex   +1 more source

Identification, characterisation and outcomes of pre‐atrial fibrillation in heart failure with reduced ejection fraction

ESC Heart Failure, EarlyView.
Abstract Aims Atrial fibrillation (AF) in heart failure with reduced ejection fraction (HFrEF) has prognostic implications. Using a machine learning algorithm (FIND‐AF), we aimed to explore clinical events and the cardiac magnetic resonance (CMR) characteristics of the pre‐AF phenotype in HFrEF.
Anna Helbitz, Ramesh Nadarajah, Lan Mu, Harriet Larvin, Hesham Ismail, Ali Wahab, Patrick Thompson, Peter Harrison, Mohammad Harris, Tobin Joseph, Sven Plein, Mark Petrie, Marco Metra, Jianhua Wu, Peter Swoboda, Chris P. Gale   +15 more
wiley   +1 more source

C-type natriuretic peptide promotes human granulosa cell growth and estradiol production: Implications for early follicle development. [PDF]

Reprod Med Biol
Sato Y, Kawamura K.
europepmc   +1 more source

Insulin Infusion Is Linked to Increased NPPC Expression in Muscle and Plasma C-type Natriuretic Peptide in Male Dogs. [PDF]

J Endocr Soc, 2021
Gregory JM, Kraft G, Farmer B, Smith MS, LaNeve DC, Williams PE, Tomasek K, Su YR, Wilson CS, Thompson MD, Cherrington AD, Coate KC.   +11 more
europepmc   +1 more source

C-type natriuretic peptide decreases soluble guanylate cyclase levels by activating the proteasome pathway

, 2003
Sergio de Frutos, Marta Saura, Francisco Javier Rivero-Vilches, Diego Rodríguez‐Puyol, Manuel Rodríguez–Puyol   +4 more
openalex   +1 more source

Pulmonary congestion relief by adding dapagliflozin to intravenous loop diuretic in acute heart failure patients

ESC Heart Failure, EarlyView.
Abstract Aims We aim to assess the efficacy of congestion relief and safety associated with adding SGLT2i (viz., dapagliflozin 10 mg) to intravenous loop diuretics within 24 h of hospital presentation in patients with acute heart failure (AHF). Methods and results A single‐centre open‐label clinical research study enrolled 98 patients admitted with an ...
Daniela Mocan, Maria Puschita, Diana Lungeanu, Adina Pop‐Moldovan, Luminita Pilat, Dan Darabantiu, Radu Jipa, Radu Ioan Lala   +7 more
wiley   +1 more source

The utilization of c-type natriuretic peptide levels on experimental muscle and kidney ischemia/reperfusion model. [PDF]

Malawi Med J
Çakırköse Ö, Kesici U, Kesici S, Sipahi M, Tokgöz VY, Güvendi GF, Avcı E, Şen TM, Kara H, Tosun A, Küçükarslan MN.   +10 more
europepmc   +1 more source

Iron deficiency in heart failure: Epidemiology, diagnostic criteria and treatment modalities

ESC Heart Failure, Volume 12, Issue 2, Page 723-726, April 2025.
Stephan von Haehling
wiley   +1 more source